dc.contributorBrambila-Tapia, A.J.L., Institute de Genética Humana, CUCS, Universidad de GuadalajaraGuadalajara,Jalisco, Mexico, División de Genica, Centrode Investigación Biom and Iica de Occidente (CIBO), Institute Mexicano del Seguro Social (IMSS), Sierra Mojada # 800Guadalajara, Mexico; Neira, V.A., Institute de Genética Humana, CUCS, Universidad de GuadalajaraGuadalajara,Jalisco, Mexico, División de Genica, Centrode Investigación Biom and Iica de Occidente (CIBO), Institute Mexicano del Seguro Social (IMSS), Sierra Mojada # 800Guadalajara, Mexico; Vasquez-Velasquez, A.I., División de Genica, Centrode Investigación Biom and Iica de Occidente (CIBO), Institute Mexicano del Seguro Social (IMSS), Sierra Mojada # 800Guadalajara, Mexico; Jimenez-Arredondo, R.E., Institute de Genética Humana, CUCS, Universidad de GuadalajaraGuadalajara,Jalisco, Mexico, División de Genica, Centrode Investigación Biom and Iica de Occidente (CIBO), Institute Mexicano del Seguro Social (IMSS), Sierra Mojada # 800Guadalajara, Mexico; Chavez-Gonzalez, E.L., División de Genica, Centrode Investigación Biom and Iica de Occidente (CIBO), Institute Mexicano del Seguro Social (IMSS), Sierra Mojada # 800Guadalajara, Mexico, Dept. Fannacología, CUCS, Universidad de GuadalajaraGuadalajara Jalisco, Mexico; Picos-Cardenas, V.J., Laboratory de Genetica Humana, Unidad de Investigaci6n, Universidad Autdnomade SinaloaCuliacán Sinaloa, Mexico; Fletes-Rayas, A.L., Institute de Genética Humana, CUCS, Universidad de GuadalajaraGuadalajara,Jalisco, Mexico; Figuera, L.E., Institute de Genética Humana, CUCS, Universidad de GuadalajaraGuadalajara,Jalisco, Mexico, División de Genica, Centrode Investigación Biom and Iica de Occidente (CIBO), Institute Mexicano del Seguro Social (IMSS), Sierra Mojada # 800Guadalajara, Mexico
dc.creatorBrambila-Tapia, A.J.L.
dc.creatorNeira, V.A.
dc.creatorVasquez-Velasquez, A.I.
dc.creatorJimenez-Arredondo, R.E.
dc.creatorChavez-Gonzalez, E.L.
dc.creatorPicos-Cardenas, V.J.
dc.creatorFletes-Rayas, A.L.
dc.creatorFiguera, L.E.
dc.date.accessioned2015-11-19T18:52:05Z
dc.date.accessioned2022-11-02T14:14:32Z
dc.date.available2015-11-19T18:52:05Z
dc.date.available2022-11-02T14:14:32Z
dc.date.created2015-11-19T18:52:05Z
dc.date.issued2014
dc.identifierhttp://hdl.handle.net/20.500.12104/67335
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84908153588&partnerID=40&md5=593e87a378d461f6e43ef007debbaa87
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4993818
dc.description.abstractPure 9p trisomy derived from a terminal balanced unrecipwcal translocation: The 9p trisomy is a relatively frequent disorder, while pure 9p trisomies are less frequent and usually derived from 9;22 translocations, duplications or 9p extra chromosomes. Here we report a patient with pure trisomy 9p derived from a terminal balanced unreciprocal translocation. The patient derived to the genetic service by psychomotor delay, presented at 2 years and 11 months: Short stature, open anterior fontanelle, dysplastic ears, facial dysmorphisms, long and broad first toes with hypoplastic nails, central nervous system and skeletal alterations. The patient karyotype was: 46,XY,dcr(10)t(9;l0) (pl3.1;qter)mat while the mother karyotype was: 46,XX,t(9;10)(pl3.1;qter). The presence of the subtelomeric region of lOq showed by FISH as well as the duplication of 9p subtelomere was further confirmed with multiplex ligation dependent probe amplification (MLPA) for the subtelomeric region of all chromosomes. The mechanism of formation seems to be due to a telomere break in lOq leading to loss of tclomeric functions, permitting the 9p fusion; this has been supported with molecular probes showing telomere shortening in interstitial telomeric repeats, which are unable to prevent chromosome fusion. This is one of the few cases reported with terminal translocations (not jumping) preserving the subtelomeric region and highlights the importance of subtelomeric probes in terminal arrangements, and the utility of molecular probes, such as MLPA in defining this kind of abnormalities. In the clinical context, the patient presented a high proportion of 9p trisomy features which is expected considering the large 9p segment involved and the presence of the critical region 9p22.
dc.relationGenetic Counseling
dc.relation25
dc.relation3
dc.relation289
dc.relation297
dc.relationScopus
dc.relationWOS
dc.titlePure 9p trisomy derived from a terminal balanced unreciprocal translocation
dc.typeArticle


Este ítem pertenece a la siguiente institución